Henry Schein Inc.

Anthony Providenti is Vice President - Corporate Business Development and Special Counsel at Henry Schein, Inc., a Fortune 500 healthcare company. At Henry Schein, Anthony is responsible for mergers and acquisitions and other strategic transactions that drive growth and profitability. Anthony previously served as a senior attorney in Henry Schein's legal department. Prior to joining Henry Schein, Anthony was a senior corporate and transactional attorney with the New York office of Gibson, Dunn & Crutcher LLP, an international law firm. Anthony received a J.D. from Fordham University School of Law where he was a Notes and Articles Editor of the Fordham Law Review, and a B.S. from the College of Business and Economics at Lehigh University. Anthony and his wife, Jane, have three children including a son named Troy with Trisomy 21. Their fundraising/awareness-raising team, Troy's Boys and Girls, has benefited a number of Down syndrome-related causes.

Mr. Benjamin has been Executive Vice President and Chief Administrative Officer since February 2000. Prior to holding his current position, he was Senior Vice President of Administration and Customer Satisfaction, since 1993, and has been a Director of the Company since September 1994. Mr. Benjamin was Vice President of Distribution Operations of the Company from 1990 to 1992 and joined Henry Schein in 1988 as Director of Materials Management. Prior to joining the Company, Mr. Benjamin served in various positions over 10 years at Estee Lauder.

Mr. David is now in his 18th year with Henry Schein, Inc., currently serving as Corporate Senior Vice President and Chief Compliance Officer. Mr. David joined the Company as General Counsel and subsequently held the position of head of Human Resources, Regulatory Affairs and Security. He assumed the post of Chief Compliance Officer in 2005, which expands his management reach over Regulatory Affairs and Security and adds the global compliance function, focusing on corporate integrity, governance, and business ethics. In this role, Mr. David interacts closely with virtually every infrastructure and business division within Henry Schein. Prior to joining Henry Schein, Mr. David was a practicing attorney in New York and New Jersey specializing in corporate and commercial law. His perspective on compliance and regulatory matters is particularly informed by his own and Henry Schein’s concern with global healthcare.

Now in his 21st year with Henry Schein, Inc., Mr. Paladino has held the position of Executive Vice President and Chief Financial Officer at the Company since 2000, and has been Chief Financial Officer since 1993. He has been a member of the Company’s Board of Directors since 1994, a member of the Executive Management Committee since 1992, and a member of the Executive Committee of the Board of Directors since 1994. Mr. Paladino’s responsibilities include the corporate oversight and strategic direction of business units as well as direct responsibility for Corporate Finance Services. These corporate services include Financial Reporting, Financial Planning, Treasury, Investor Relations, Internal Audit and Taxation. Mr. Paladino also works with the Corporate Business Development Group on Mergers and Acquisition activities. From 1990 to 1992, Mr. Paladino served as Vice President and Treasurer for Henry Schein, and from 1987 to 1990 as Corporate Controller. He led the Company through the corporate reorganization and separation from Schein Pharmaceutical in 1993 and through the IPO process in 1995. A certified public accountant, Mr. Paladino was with BDO Seidman, LLP as Manager, General Audit and Consulting Services prior to joining Henry Schein in 1987. Mr. Paladino is a member of the American Institute of Certified Public Accountants (AICPA), the New York State Society of Public Accountants (NYSSCPA) and the Institute of Management Accountants (IMA). He holds a Bachelor of Business Administration degree from Bernard M. Baruch College.

Mr. Zack has been responsible for Henry Schein’s International Group since 1989, when he joined Team Schein, and currently holds the position of President of the International Group. Under his leadership, the International Group has grown to include operations in 17 countries outside of the North America, with sales of $1.4 billion in 2006, representing 29% of total Company sales. Before joining Henry Schein, Mr. Zack was employed by Polymer Technology (a subsidiary of Bausch & Lomb) as Vice President of International Operations from 1984 to 1989. Prior to this, Mr. Zack was employed by Gruenenthal GmbH, a German pharmaceutical company, as Manager of International subsidiaries from 1975 to 1984. As part of his various foreign assignments at Gruenenthal, Mr. Zack worked and lived in Tehran, Iran; Quito, Ecuador; Lima, Peru; Madrid, Spain; and Bogotá, Colombia, before being transferred to Boston, Massachusetts. Mr. Zack is the representative of the Dental Trade Alliance to International Dental Manufacturers. He is fluent in six languages and holds a bachelor’s degree in economics from Tel Aviv University.

Keith D. Drayer is Vice President of Henry Schein Financial Services at Henry Schein, Inc., which is the largest provider of healthcare products, and services to office-based practitioners in the combined North American and European markets. Mr. Drayer is responsible for Henry Schein Financial Services and Henry Schein Professional Practice Transitions, which help healthcare practitioners operate successful practices. A leader in the field of professional dentistry, Mr. Drayer is active with the Dental Trade Alliance, serves on board of Dr. Edward B. Shils Entrepreneurial Education Fund and is a member of the Alpha Omega Corporate Roundtable. He also works with the National Dental Association and Hispanic Dental Association on matters of dental diversity and practice ownership. He is our liaison to Henry Schein, which consistently and generously participates in supplying our dental clinic and other general support of our organization.

Mr. Mlotek, now in his 14th year with Henry Schein, Inc., currently serves as Executive Vice President of Corporate Business Development, a position he has held since 2004, and he has been a member of the Company’s Board of Directors since 1995. In his current role, Mr. Mlotek has four main priorities: worldwide merger & acquisition activity for the Company; business development, including important supplier partnership arrangements; strategic planning; and P&L responsibility for certain non-core businesses that represent approximately $450 million of revenue. Prior to holding his current position, Mr. Mlotek served as the Company's Senior Vice President of Corporate Business Development, and before that, upon joining the Company in 1994, was Vice President, General Counsel, and Secretary. Prior to joining Henry Schein, Mr. Mlotek was a partner in the law firm of Proskauer Rose LLP and counsel to the Company, specializing in mergers and acquisitions, corporate reorganizations and tax law. At Proskauer, since 1989, Mr. Mlotek worked very closely with Henry Schein on various corporate matters. Prior to joining Proskauer, Mr. Mlotek was a partner in the law firm of Feit & Ahrens. Mr. Mlotek graduated the Columbia University School of Law with high honors in 1980. He received an LLM in Taxation from New York University School of Law in 1985, also graduating with honors. Mr. Mlotek graduated summa cum laude with a B.S. degree in accounting from the Herbert Lehman University of the City College of New York in 1977. Mr. Mlotek has been active in various charitable organizations, most notably the Workmen's Circle, a Jewish fraternal organization that he served as President of from 1996-2000. During that time, he served on the Conference of Presidents of Major Jewish Organizations. Mr. Mlotek is a member of the New York State Bar Association.

Rodi Rozin has extensive experience in business development, mergers and acquisitions, corporate reorganizations, business integrations and project management. He is currently a business development executive at Henry Schein, Inc., a Fortune 500 company specializing in the distribution of medical products and technology worldwide. Prior to joining Henry Schein, Mr. Rozin played a key role in the Chapter 11 reorganization of Goss International, a worldwide manufacturer of printing press systems, and advised clients on mergers and acquisitions at PricewaterhouseCoopers Securities. Mr. Rozin received his BA in Economics & Mathematics from Columbia University (1997) and MBA with Honors from Columbia Business School (2003).

Mr. Komaroff joined Henry Schein in December 2003 as Senior Advisor and a Member of the Executive Management Committee, concentrating in business development and acquisitions, international matters, and legal and regulatory affairs. Prior to joining the Company, Mr. Komaroff served as an advisor on legal and board-related issues and provides a wealth of experience in the corporate, commercial and healthcare worlds. Mr. Komaroff was formerly the Chairman of Proskauer Rose LLP, the Company’s principal law firm and one of the largest firms in the nation, and he led the firm through a period of significant growth. Prior to being elected as Chair of the firm, Mr. Komaroff was the Chair of its Corporate Department. As a general corporate and securities lawyer with extensive experience in mergers and acquisitions and international transactions, Mr. Komaroff has been involved with hundreds of transactions, dozens of securities filings, and the widest variety of sophisticated issues in which he served as a counselor, advisor, strategist and confidant. Mr. Komaroff has been active in civic and philanthropic matters, concentrating in the healthcare field. He is a Director of Beth Israel Medical Center; as a Director and member of the Executive Committee of St. Luke’s-Roosevelt Hospital Center and Continuum Health Partners, one of the largest consortiums of hospitals and healthcare facilities in the New York metropolitan area; and a regent of Long Island College Hospital. In addition, he serves on the Board of Directors of Overseas Shipholding Group (NYSE), The Edmond de Rothschild Foundation, and the Westhampton Beach Performing Arts Center. For more than 10 years, Mr. Komaroff was a member of the New York State Hospital Review and Planning Council, having received multiple gubernatorial appointments to this position. And at Mayor Bloomberg’s recommendation, he was recently appointed as a Director of the New York City Economic Development Corporation. Mr. Komaroff earned his bachelor’s degree from Cornell University and his J.D. from Cornell Law School. He was Editor-in-Chief of the Cornell Law Review, a member of the Order of the Coif, and the winner of several academic honors.

Mr. Alperin is a business consultant who retired from Hasbro Inc. in 1996 after 11 years in various senior executive positions, including Vice Chairman and Director. Mr. Alperin is currently on the board of Henry Schein, Inc., K'NEX Industries, Inc. and The Hain Celestial Group Inc. Mr. Alperin practiced securities law in New York City from 1966 to 1985, finishing his legal career with the law firm of Fenwick & West, where he was a managing partner. Mr. Alperin is Chairman of the Audit Committee.

Array

Karyn Mashima has been a director of the Company since May 2008. Ms. Mashima, a private consultant, served as Senior Vice President, Strategy & Technology of Avaya, a leading global provider of business communications applications, systems, and services from 2000 to January, 2009. Ms. Mashima was responsible for overall business and technology strategies at Avaya, including CTO, architecture and Research, business planning, market assessment, and competitive analysis. She was also executive sponsor for numerous Fortune 500 companies. With over 25 years of experience in leading product teams and developing strategies to maximize customer value and business benefits, Ms. Mashima has held similar positions at a number of leading technology companies. Prior to her position at Avaya, Ms. Mashima held a similar post in the Enterprise Networks unit of Lucent Technologies. She joined AT&T in 1994 as a key leader in the formation of Lucent's Data Networking Systems unit. Ms. Mashima began her career as a product manager at Xerox Corp.'s Office Systems division in Palo Alto, California during the early years of Ethernet and the Star workstation. Ms. Mashima moved to Hewlett-Packard in 1984, where she championed the business case for HP OpenView, then introduced it to the marketplace and established it as the open systems platform of choice for network management. Ms. Mashima also served as Vice President of Proteon Inc. in 1993 and 1994 and Vice President of Network Equipment Technologies in 1991 and 1992. Ms. Mashima is a recognized industry leader, and frequently presents at major industry conferences. She was named a "Woman of Influence for 2005" by NJBiz magazine and to the "First Annual List of Tech Women to Watch" by the executive search firm Christian & Timbers. Ms. Mashima earned her M.B.A. from the University of New Mexico's Robert O. Anderson Graduate School of Management and her B.S. degree with distinction from the University of New Mexico.

Louis Sullivan served as U.S. Secretary of Health and Human Services from 1989 to 1993. Prior to and following his service as HHS Secretary, he was President of Morehouse School of Medicine, which he now serves as President Emeritus. He is co-chair of The Presidential Advisory Council on HIV/AIDS. A graduate of Morehouse College, he earned his medical degree from Boston University, and is certified in internal medicine and hematology. The recipient of 45 honorary degrees, he served on the faculties of the medical schools at Harvard, Seton Hall, and Boston universities before arriving at Morehouse in 1975. He was also the founding president of the Association of Minority Health Professions Schools.

Mr. Schein has been a director of the Company since September 1994, and has provided consulting services to the Company since 1982. Mr. Schein founded Schein Dental Equipment Corp., a subsidiary of the Company. Prior to founding Schein Dental Equipment Corp., Mr. Schein held various management and executive positions with the Company.

Mr. Brons has been a director of the Company since April 2005. A member of the Akzo Nobel Board of Management from 1994-2002, he led all of the company's pharmaceutical business units, including human and veterinary pharmaceuticals, OTCs, generics, diagnostics and pharmaceutical active ingredients. Since retiring from the Akzo Nobel Board of Management in 2002, Mr. Brons has served on the Supervisory Boards for Akzo Nobel Netherlands, for Organon BioSciences Netherlands, and for IBM Netherlands. He was honored in 1996 by Her Majesty the Queen with the decoration of Knight of the Order of Lion of the Kingdom of the Netherlands, the country's highest civilian order, conferred for his meritorious achievements for Akzo Nobel and other international activities.

Philip A. Laskawy retired from Ernst & Young in September 2001, after having held several positions during his employment there from 1961 to 2001, including serving as chairman and chief executive officer from 1994 until his retirement in 2001. In 2006-2007, he served as chairman of the International Accounting Standards Committee Foundation, which sets accounting standards in more than 100 countries. Mr. Laskawy currently serves on the Boards of Directors of General Motors Corporation, Henry Schein, Inc., Lazard Ltd., and Loews Corporation.